Myocardial Infarction News and Research

RSS

Venous thromboembolism in the U.S.

Venous thrombosis (VTE), the formation of blood clots in a vein, is a major health problem for hospitalized patients in the United States.

16 Jul 2007

Women who have suffered heart attacks have higher rates of depression compared to men

Women who have suffered heart attacks have higher rates of lingering depressive symptoms compared to their male counterparts, a University of Alberta and McGill University study shows.

16 Jul 2007

Caraco Pharmaceutical Labs announces FDA approval to market generic Tenormin

Caraco Pharmaceutical Laboratories has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Atenolol Tablets USP (atenolol).

12 Jul 2007

Heart attack death rates appear lower at 'America's best hospitals'

Individuals admitted for heart attack to a hospital ranked as one of America's Best by U.S. News & World Report are less likely to die within 30 days than those admitted to a non-ranked hospital, according to a report in the July 9 issue of Archives of Internal Medicine.

10 Jul 2007

Women's mortality rates for cardiovascular disease differ widely among hospitals

Women treated for cardiovascular disease at the nation's best- performing hospitals have a 39 percent lower risk-adjusted mortality rate when compared with women at the nation's poorest-performing hospitals, according to the fourth annual HealthGrades Women's Health Outcomes in U.S. Hospitals study.

26 Jun 2007

Portion-control dishes may help obese diabetics lose weight

A plate and cereal bowl with markers for proper portion sizes appear to help obese patients with diabetes lose weight and decrease their use of glucose-controlling medications, according to a report in the June 25 issue of Archives of Internal Medicine.

26 Jun 2007

Obese heart attack patients more likely to survive after treatment than normal weight patients

Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).

20 Jun 2007

Multidisciplinary approach to treatment of heart attacks a success

Acute heart attacks can be successfully treated through a multidisciplinary team approach involving Emergency Medical Services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.

19 Jun 2007

Swift system for heart attack care improves treatment

Heart attack patients received lifesaving care up to an hour sooner after an Indiana hospital implemented a novel protocol to rapidly activate the cardiac catheterization lab, researchers reported in Circulation: Journal of the American Heart Association.

16 Jun 2007

Black Medicare patients less likely to receive angioplasty following a heart attack

A large study has found that black Medicare patients are less likely than white patients to receive blood vessel opening procedures such as angioplasty following a heart attack, whether they are admitted to hospitals that provide or do not provide these procedures, but also experience higher mortality rates at 1 year, according to a study in the June 13 issue of JAMA: The Journal of the American Medical Association.

14 Jun 2007

GSK strongly disagrees with conclusions reached in NEJM article on Avandia

GlaxoSmithKline has issued the following response to an article in the New England Journal of Medicine (NEJM) on Avandia (rosiglitazone maleate), a widely used and highly effective treatment for type 2 diabetes.

22 May 2007

Off-label and untested use of drug-coated stents is common in U.S. practice

The off-label and untested use of drug-coated stents in the treatment of coronary artery blockage is common in U.S. practice, and ischemic complication rates are higher among patients receiving drug-coated stents for off-label indications, according to two studies in the May 9 issue of Journal of the American Medical Association.

9 May 2007

Ischemic-targeted approach to angioplasty among asymptomatic survivors of heart attack

When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia", according to a study in the May 9 issue of Journal of the American Medical Association.

9 May 2007

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

The U.S. Food and Drug Administration (FDA) has approved a new indication for FRAGMIN (dalteparin sodium injection), for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence of VTE in patients with cancer.

4 May 2007

Improving outcomes for patients with acute coronary syndrome

Recent changes in the recommended treatments used for patients hospitalized for acute coronary syndromes, such as a heart attack, are associated with reductions in the rates of heart failure, stroke, heart attack and death, according to a study in the May 2 issue of JAMA .

2 May 2007

Efforts to standardize heart care are working

People who suffer a heart attack or severe chest pain today are much less likely to die, or to experience long-lasting effects, than their counterparts even a few years ago, according to a new international study in the May 3 issue of the Journal of the American Medical Association.

2 May 2007

Caution against over-aggressive use of erythropoiesis-stimulating agents for cancer-related anemia

Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.

1 May 2007

Ranbaxy receives approval to manufacture Pravastatin Sodium tablets in U.S.

Ranbaxy Pharmaceuticals has announced that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Pravastatin Sodium Tablets (Pravastatin), 10 mg, 20 mg, 40 mg and 80 mg, with 180-day market exclusivity in the U.S. healthcare system for the 80 mg strength.

27 Apr 2007

HIV linked to increased risk of heart attack

Researchers from Massachusetts General Hospital (MGH) have found that infection with HIV, the virus that causes AIDS, is also associated with increased risk of myocardial infarction or heart attack.

25 Apr 2007

Sticking with guidelines for acute coronary syndromes benefits even very elderly patients

Some say age 90 is the new age 70. If so, there's never been a better time for elderly patients to discuss with family and physicians just how aggressive medical care should be in case of a threatened or definite heart attack.

24 Apr 2007